2023 US SUMMIT OF LABORATORY MEDICINE INNOVATIONS
January 12th-14th, The Woodlands, Texas
Conference Information
JANUARY 12TH-14TH, 2023 at The Woodland Resort, TX
Hosting by: Alliance for Laboratory Medicine Innovation supported by Foundation for Laboratory Medicine Innovation (FLMI)
Co-hosting With:
-
North American Chinese Clinical Chemists Association (NACCCA)
-
Chinese American Pathologist Association/Clinical Pathology Education Division (CAPA-CP)
-
Sino-American Pharmaceutical Professionals Association (SAPA) - Medical Device & Diagnostic Community (MDDC)
Meeting Theme
Emerging Diagnostic Innovations in Laboratory Medicine, include topics:
-
Existing pain points that urgently need technological breakthroughs
-
Technology innovation and emerging diagnostics
-
Technology implementation in clinical settings
-
Market opportunity and collaboration among key stakeholders
-
Regulatory strategies in post-pandemic era
-
Artificial intelligence and digital
-
Diagnostic topics, e.g. epigenetic markers in tumor diagnosis, infectious disease diagnostics, point-of-care, early diagnosis of high risk diseases, companion diagnostics, laboratory tools for immuno & cell-therapy.
Invited Speakers
Medical directors from:
MD Anderson Cancer Center
Memorial Sloan Kettering Cancer Center
City of Hope Cancer Center
University of Kansas Medical Center
Tulane University Medical Center
UTMB Health at Galveston
Houston Methodist Hospital
UT Southwestern Medical Center
Weill Cornell Medical Center
Founders or leaders from IVD Industry
Danaher and Cepheid China Dx Platform
Wanda Henry
AdvanBio
Biotime Biotechnology
Leaders from Professional Associations:
Alliance of Laboratory Medicine Innovation
North American Chinese Clinical Chemists Association
Chinese American Pathologist Association/Clinical Pathology Education Division
Sino-American Pharmaceutical Professionals Association-Medical Device & Diagnostic Community (MDDC)
Meeting Speakers
Zhenya Tang
MD, PhD, FACMG
University of Nebraska Medical Center
Distinguished Professor, Director, Human Genetics & Cytogenetics
Dongfeng Chen
PhD, F(ACHI)
Duke University Medical Center
Director, Clinical Transplantation Immunology
Youli Zu
MD, PhD
Houston Methodist Hospital
Section Chief, Hematopathology
Yongmei Maggie Li
PhD
Emerther LLC
CEO, Emerther; President, SAPA 2023
Lu Wang
MD, PhD, FACMG
St Jude Children's Hospital
Director, Clinical Molecular
Siaw Li Chan
PhD, DABCC
Nuvance Health
Director of Chemistry, Immunology and POCT
Xin Yi
PhD, DABCC
Houston Methodist Hospital
Director, Clinical Chemistry and Immunology
Qing Meng
MD, PhD, DABCC
MD Anderson Cancer Center
Section Chief, Clinical Chemistry
Rongrong Huang
PhD, DABCC
Baylor College of Medicine
Director, Clinical Chemistry
Hui Chen
MD, PhD
MD Anderson Cancer Center
Director, Clinical Molecular
Sarina Yang
PhD, DABCC
Weill Cornell Medicine
Director, Clinical Chemistry
Charles Lee
PhD
Advan-Bio
CEO
Jing Cao
PhD, DABCC
UT Southwestern Medical Center
Director, Clinical Chemistry, Metabolics, POCT
Young Wang
PhD
Wanda Henry Co.
Founder and CEO
Wenli Zhou
PhD
XYZlab LLC
Founder and Director
Fei Ye
MD, PhD
Memorial Sloan Kettering Cancer Center
Director, HLA and Molecular
kai Ying
PhD
Baylor Genetics
Bioinformatics
Harris Zhang
PhD
PicoImmune LLC
Founder and CEO
Zhen Zhao
PhD, DABCC
Weill Cornell Medicine
Clinical Chemistry Director; ADLM Academy President
Yi-Wei Tang
MD, PhD
Danaher China
China Division CMO
Xiao-Ming Yin
MD, PhD
Tulane University Medical Center
Chair, Pathology Department
Mingyi Chen
MD, PhD
University of Texas Southwestern Medical Center
Director, Hematopathology
Lukas Pfannenstiel
PhD
Saul Ewing LLP
Legal Consultant
Zhiyong Ding
PhD
Fynn Biotechnologies Ltd
Founder and CEO
Min Yu
MD, PhD, DABCC
Beth Israel Deaconess Medical Center, Harvard Medical School
Director, POCT
Jun Zou
MD, PhD
MD Anderson Cancer Center
Medical Director, Laboratory Medicine
Yuxin Fan
MD, PhD
Baylor College of Medicine
Hemepath Pathologist
Ruben Luo
PhD, DABCC
Stanford University Medical Center
Director, Clinical Chemistry
Joseph Zhou
PhD
Rongzhi Bio-Tech (Qingdao) Co., Ltd.
Founder and CEO
Zejuan Li
MD, PhD, FACMG
Houston Methodist Hospital
Director, Clinical Molecular
Jian Chen
MD, PhD
Houston Methodist Hospital
Director, Coagulation, Transfusion
Xinyan Lu
MD, FACMG
Northwestern University Medical Center
Professor, Medical Director, Clinical Cytogenetics
Ping Ren
MD, PhD, D(ABMM)
University of Texas Medical Brance
Professor, Medical Director, Microbiology and Immunology
Paul Breitenbecher
Breitenassociates LLC
Founder